nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimexolone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.369	1	CiPCiCtD
Rimexolone—Prednisone—prostate cancer	0.247	1	CrCtD
Rimexolone—NR3C1—prostate cancer	0.136	1	CbGaD
Rimexolone—Testolactone—Estrone—prostate cancer	0.0287	0.152	CrCrCtD
Rimexolone—NR3C1—Prednisone—prostate cancer	0.0184	1	CbGbCtD
Rimexolone—Ciclesonide—Prednisone—prostate cancer	0.00949	0.0503	CrCrCtD
Rimexolone—Hydrocortamate—Prednisone—prostate cancer	0.00793	0.042	CrCrCtD
Rimexolone—Prednicarbate—Prednisone—prostate cancer	0.00746	0.0395	CrCrCtD
Rimexolone—Testolactone—Prednisone—prostate cancer	0.00746	0.0395	CrCrCtD
Rimexolone—Fluocortolone—Prednisone—prostate cancer	0.00725	0.0384	CrCrCtD
Rimexolone—Alclometasone—Prednisone—prostate cancer	0.00705	0.0373	CrCrCtD
Rimexolone—Budesonide—Prednisone—prostate cancer	0.00686	0.0363	CrCrCtD
Rimexolone—Amcinonide—Prednisone—prostate cancer	0.00686	0.0363	CrCrCtD
Rimexolone—Flunisolide—Prednisone—prostate cancer	0.00668	0.0354	CrCrCtD
Rimexolone—Diflorasone—Prednisone—prostate cancer	0.00668	0.0354	CrCrCtD
Rimexolone—Clobetasol propionate—Prednisone—prostate cancer	0.00668	0.0354	CrCrCtD
Rimexolone—Desonide—Prednisone—prostate cancer	0.00668	0.0354	CrCrCtD
Rimexolone—Paramethasone—Prednisone—prostate cancer	0.00651	0.0345	CrCrCtD
Rimexolone—Desoximetasone—Prednisone—prostate cancer	0.00635	0.0337	CrCrCtD
Rimexolone—Fluprednidene Acetate—Prednisone—prostate cancer	0.0062	0.0329	CrCrCtD
Rimexolone—Loteprednol—Prednisone—prostate cancer	0.0062	0.0329	CrCrCtD
Rimexolone—Fluorometholone—Prednisone—prostate cancer	0.0062	0.0329	CrCrCtD
Rimexolone—Mometasone—Prednisone—prostate cancer	0.0062	0.0329	CrCrCtD
Rimexolone—Triamcinolone—Prednisone—prostate cancer	0.0062	0.0329	CrCrCtD
Rimexolone—Dexamethasone—Prednisone—prostate cancer	0.00606	0.0321	CrCrCtD
Rimexolone—Betamethasone—Prednisone—prostate cancer	0.00606	0.0321	CrCrCtD
Rimexolone—Methylprednisolone—Prednisone—prostate cancer	0.0058	0.0307	CrCrCtD
Rimexolone—Prednisolone—Prednisone—prostate cancer	0.00568	0.0301	CrCrCtD
Rimexolone—Hydrocortisone—Prednisone—prostate cancer	0.00545	0.0289	CrCrCtD
Rimexolone—Lacrimation—Estramustine—prostate cancer	0.00126	0.0473	CcSEcCtD
Rimexolone—Sensation of foreign body—Ethinyl Estradiol—prostate cancer	0.00123	0.0462	CcSEcCtD
Rimexolone—Eye infection—Estradiol—prostate cancer	0.000841	0.0317	CcSEcCtD
Rimexolone—Lacrimation increased—Estramustine—prostate cancer	0.000801	0.0302	CcSEcCtD
Rimexolone—Nerve injury—Prednisone—prostate cancer	0.000664	0.025	CcSEcCtD
Rimexolone—NR3C1—urine—prostate cancer	0.000616	0.26	CbGeAlD
Rimexolone—Photophobia—Nilutamide—prostate cancer	0.000615	0.0232	CcSEcCtD
Rimexolone—Lacrimation increased—Cabazitaxel—prostate cancer	0.000598	0.0226	CcSEcCtD
Rimexolone—Eye pain—Estramustine—prostate cancer	0.000594	0.0224	CcSEcCtD
Rimexolone—Ulcerative keratitis—Prednisone—prostate cancer	0.000574	0.0216	CcSEcCtD
Rimexolone—Cataract subcapsular—Prednisone—prostate cancer	0.000555	0.0209	CcSEcCtD
Rimexolone—Scab—Capecitabine—prostate cancer	0.000512	0.0193	CcSEcCtD
Rimexolone—Herpes simplex—Ethinyl Estradiol—prostate cancer	0.000434	0.0164	CcSEcCtD
Rimexolone—Herpes simplex—Goserelin—prostate cancer	0.000357	0.0135	CcSEcCtD
Rimexolone—SERPINA6—renal system—prostate cancer	0.000344	0.145	CbGeAlD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—TMPRSS2—prostate cancer	0.000332	0.0364	CbGpPWpGaD
Rimexolone—Rhinitis—Nilutamide—prostate cancer	0.00033	0.0124	CcSEcCtD
Rimexolone—Intraocular pressure increased—Prednisone—prostate cancer	0.000329	0.0124	CcSEcCtD
Rimexolone—Dry eye—Goserelin—prostate cancer	0.000304	0.0115	CcSEcCtD
Rimexolone—Lacrimation—Docetaxel—prostate cancer	0.000286	0.0108	CcSEcCtD
Rimexolone—Herpes simplex—Estradiol—prostate cancer	0.000283	0.0107	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—HOXB13—prostate cancer	0.000282	0.031	CbGpPWpGaD
Rimexolone—Discomfort—Abiraterone—prostate cancer	0.000264	0.00994	CcSEcCtD
Rimexolone—Oedema—Estramustine—prostate cancer	0.000263	0.00993	CcSEcCtD
Rimexolone—SERPINA6—bone marrow—prostate cancer	0.00026	0.11	CbGeAlD
Rimexolone—Oedema—Abiraterone—prostate cancer	0.000256	0.00965	CcSEcCtD
Rimexolone—Oedema—Estrone—prostate cancer	0.000252	0.00949	CcSEcCtD
Rimexolone—Keratitis—Capecitabine—prostate cancer	0.000251	0.00945	CcSEcCtD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA3—prostate cancer	0.000248	0.0273	CbGpPWpGaD
Rimexolone—Vision blurred—Degarelix—prostate cancer	0.000241	0.00909	CcSEcCtD
Rimexolone—Discomfort—Nilutamide—prostate cancer	0.000241	0.00908	CcSEcCtD
Rimexolone—Dry eye—Estradiol—prostate cancer	0.000241	0.00908	CcSEcCtD
Rimexolone—Discomfort—Flutamide—prostate cancer	0.00024	0.00904	CcSEcCtD
Rimexolone—Rhinitis—Bicalutamide—prostate cancer	0.000238	0.00898	CcSEcCtD
Rimexolone—Dysgeusia—Cabazitaxel—prostate cancer	0.000236	0.0089	CcSEcCtD
Rimexolone—Pharyngitis—Bicalutamide—prostate cancer	0.000236	0.00889	CcSEcCtD
Rimexolone—Oedema—Nilutamide—prostate cancer	0.000234	0.00881	CcSEcCtD
Rimexolone—Oedema—Flutamide—prostate cancer	0.000233	0.00877	CcSEcCtD
Rimexolone—NR3C1—prostate gland—prostate cancer	0.000221	0.0932	CbGeAlD
Rimexolone—Oedema—Estradiol valerate/Dienogest—prostate cancer	0.00022	0.00828	CcSEcCtD
Rimexolone—Discomfort—Degarelix—prostate cancer	0.000215	0.00811	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—KLK3—prostate cancer	0.000214	0.0235	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—SPOCK1—prostate cancer	0.000214	0.0235	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—KLF15—prostate cancer	0.000214	0.0235	CbGpPWpGaD
Rimexolone—Discomfort—Cabazitaxel—prostate cancer	0.000203	0.00764	CcSEcCtD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA1—prostate cancer	0.000202	0.0222	CbGpPWpGaD
Rimexolone—Rhinitis—Ethinyl Estradiol—prostate cancer	0.000201	0.00759	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—KLK2—prostate cancer	0.000201	0.0221	CbGpPWpGaD
Rimexolone—Pharyngitis—Ethinyl Estradiol—prostate cancer	0.000199	0.00751	CcSEcCtD
Rimexolone—Oedema—Cabazitaxel—prostate cancer	0.000197	0.00742	CcSEcCtD
Rimexolone—Hypotension—Degarelix—prostate cancer	0.000195	0.00736	CcSEcCtD
Rimexolone—Lacrimation—Epirubicin—prostate cancer	0.000193	0.00726	CcSEcCtD
Rimexolone—NR3C1—seminal vesicle—prostate cancer	0.000187	0.0789	CbGeAlD
Rimexolone—Pruritus—Estramustine—prostate cancer	0.000186	0.00703	CcSEcCtD
Rimexolone—Hypotension—Cabazitaxel—prostate cancer	0.000184	0.00693	CcSEcCtD
Rimexolone—Lacrimation increased—Docetaxel—prostate cancer	0.000182	0.00687	CcSEcCtD
Rimexolone—Lacrimation—Doxorubicin—prostate cancer	0.000178	0.00672	CcSEcCtD
Rimexolone—Pruritus—Estrone—prostate cancer	0.000178	0.00671	CcSEcCtD
Rimexolone—Lacrimation increased—Capecitabine—prostate cancer	0.000177	0.00665	CcSEcCtD
Rimexolone—Herpes simplex—Capecitabine—prostate cancer	0.000177	0.00665	CcSEcCtD
Rimexolone—Keratitis—Epirubicin—prostate cancer	0.000175	0.00659	CcSEcCtD
Rimexolone—Oedema—Bicalutamide—prostate cancer	0.000169	0.00636	CcSEcCtD
Rimexolone—Amcinonide—ANXA1—prostate cancer	0.000167	0.0742	CrCbGaD
Rimexolone—Rhinitis—Goserelin—prostate cancer	0.000166	0.00624	CcSEcCtD
Rimexolone—Pruritus—Nilutamide—prostate cancer	0.000165	0.00623	CcSEcCtD
Rimexolone—Headache—Estramustine—prostate cancer	0.000165	0.00622	CcSEcCtD
Rimexolone—Pruritus—Flutamide—prostate cancer	0.000165	0.00621	CcSEcCtD
Rimexolone—Rhinitis—Conjugated Estrogens—prostate cancer	0.000164	0.00619	CcSEcCtD
Rimexolone—Pharyngitis—Goserelin—prostate cancer	0.000164	0.00618	CcSEcCtD
Rimexolone—Pharyngitis—Conjugated Estrogens—prostate cancer	0.000162	0.00612	CcSEcCtD
Rimexolone—NR3C1—epithelium—prostate cancer	0.000162	0.0685	CbGeAlD
Rimexolone—Keratitis—Doxorubicin—prostate cancer	0.000162	0.00609	CcSEcCtD
Rimexolone—Headache—Estrone—prostate cancer	0.000158	0.00594	CcSEcCtD
Rimexolone—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000155	0.00586	CcSEcCtD
Rimexolone—NR3C1—renal system—prostate cancer	0.000151	0.0636	CbGeAlD
Rimexolone—Dry eye—Capecitabine—prostate cancer	0.00015	0.00566	CcSEcCtD
Rimexolone—NR3C1—urethra—prostate cancer	0.000148	0.0624	CbGeAlD
Rimexolone—Pruritus—Degarelix—prostate cancer	0.000148	0.00557	CcSEcCtD
Rimexolone—Discomfort—Ethinyl Estradiol—prostate cancer	0.000147	0.00554	CcSEcCtD
Rimexolone—Headache—Nilutamide—prostate cancer	0.000146	0.00552	CcSEcCtD
Rimexolone—Headache—Flutamide—prostate cancer	0.000146	0.0055	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—FOXA1—prostate cancer	0.000143	0.0157	CbGpPWpGaD
Rimexolone—Oedema—Ethinyl Estradiol—prostate cancer	0.000143	0.00538	CcSEcCtD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—prostate cancer	0.000142	0.0156	CbGpPWpGaD
Rimexolone—Dysgeusia—Conjugated Estrogens—prostate cancer	0.00014	0.00526	CcSEcCtD
Rimexolone—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000138	0.00519	CcSEcCtD
Rimexolone—Vision blurred—Goserelin—prostate cancer	0.000136	0.00511	CcSEcCtD
Rimexolone—Vision blurred—Conjugated Estrogens—prostate cancer	0.000134	0.00506	CcSEcCtD
Rimexolone—Rhinitis—Estradiol—prostate cancer	0.000131	0.00495	CcSEcCtD
Rimexolone—Headache—Degarelix—prostate cancer	0.000131	0.00493	CcSEcCtD
Rimexolone—Eye pain—Capecitabine—prostate cancer	0.000131	0.00493	CcSEcCtD
Rimexolone—Pharyngitis—Estradiol—prostate cancer	0.00013	0.0049	CcSEcCtD
Rimexolone—Headache—Cabazitaxel—prostate cancer	0.000123	0.00465	CcSEcCtD
Rimexolone—Lacrimation increased—Epirubicin—prostate cancer	0.000123	0.00464	CcSEcCtD
Rimexolone—Herpes simplex—Epirubicin—prostate cancer	0.000123	0.00464	CcSEcCtD
Rimexolone—Rhinitis—Mitoxantrone—prostate cancer	0.000122	0.00461	CcSEcCtD
Rimexolone—Pharyngitis—Mitoxantrone—prostate cancer	0.000121	0.00457	CcSEcCtD
Rimexolone—Discomfort—Goserelin—prostate cancer	0.000121	0.00456	CcSEcCtD
Rimexolone—Pruritus—Bicalutamide—prostate cancer	0.000119	0.0045	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.000119	0.0131	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—RXRA—prostate cancer	0.000118	0.013	CbGpPWpGaD
Rimexolone—Oedema—Goserelin—prostate cancer	0.000117	0.00443	CcSEcCtD
Rimexolone—Oedema—Conjugated Estrogens—prostate cancer	0.000116	0.00438	CcSEcCtD
Rimexolone—NR3C1—bone marrow—prostate cancer	0.000114	0.0481	CbGeAlD
Rimexolone—Lacrimation increased—Doxorubicin—prostate cancer	0.000114	0.00429	CcSEcCtD
Rimexolone—Herpes simplex—Doxorubicin—prostate cancer	0.000114	0.00429	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—LAMC1—prostate cancer	0.000113	0.0124	CbGpPWpGaD
Rimexolone—Dysgeusia—Estradiol—prostate cancer	0.000112	0.00421	CcSEcCtD
Rimexolone—Hypotension—Goserelin—prostate cancer	0.00011	0.00414	CcSEcCtD
Rimexolone—Hypotension—Conjugated Estrogens—prostate cancer	0.000109	0.0041	CcSEcCtD
Rimexolone—Headache—Bicalutamide—prostate cancer	0.000106	0.00399	CcSEcCtD
Rimexolone—Dry eye—Epirubicin—prostate cancer	0.000105	0.00395	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—KLF6—prostate cancer	0.000104	0.0115	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—LIFR—prostate cancer	0.000104	0.0115	CbGpPWpGaD
Rimexolone—Dysgeusia—Mitoxantrone—prostate cancer	0.000104	0.00392	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—MT2A—prostate cancer	0.000104	0.0114	CbGpPWpGaD
Rimexolone—Pruritus—Ethinyl Estradiol—prostate cancer	0.000101	0.0038	CcSEcCtD
Rimexolone—Vision blurred—Mitoxantrone—prostate cancer	0.0001	0.00377	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—PENK—prostate cancer	9.83e-05	0.0108	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—LAMC1—prostate cancer	9.81e-05	0.0108	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—prostate cancer	9.73e-05	0.0107	CbGpPWpGaD
Rimexolone—NR3C1—testis—prostate cancer	9.73e-05	0.0411	CbGeAlD
Rimexolone—Dry eye—Doxorubicin—prostate cancer	9.68e-05	0.00365	CcSEcCtD
Rimexolone—Discomfort—Estradiol—prostate cancer	9.59e-05	0.00362	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—prostate cancer	9.41e-05	0.0103	CbGpPWpGaD
Rimexolone—Oedema—Estradiol—prostate cancer	9.31e-05	0.00351	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—BMP7—prostate cancer	9.2e-05	0.0101	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—HNF1B—prostate cancer	9.2e-05	0.0101	CbGpPWpGaD
Rimexolone—Eye pain—Epirubicin—prostate cancer	9.11e-05	0.00343	CcSEcCtD
Rimexolone—Discomfort—Mitoxantrone—prostate cancer	8.94e-05	0.00337	CcSEcCtD
Rimexolone—Headache—Ethinyl Estradiol—prostate cancer	8.94e-05	0.00337	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—ID3—prostate cancer	8.87e-05	0.00974	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptors—ESR2—prostate cancer	8.72e-05	0.00957	CbGpPWpGaD
Rimexolone—Oedema—Mitoxantrone—prostate cancer	8.67e-05	0.00327	CcSEcCtD
Rimexolone—Dysgeusia—Etoposide—prostate cancer	8.65e-05	0.00326	CcSEcCtD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—prostate cancer	8.57e-05	0.00942	CbGpPWpGaD
Rimexolone—Rhinitis—Docetaxel—prostate cancer	8.46e-05	0.00319	CcSEcCtD
Rimexolone—Eye pain—Doxorubicin—prostate cancer	8.43e-05	0.00318	CcSEcCtD
Rimexolone—Pharyngitis—Docetaxel—prostate cancer	8.37e-05	0.00316	CcSEcCtD
Rimexolone—Pruritus—Goserelin—prostate cancer	8.31e-05	0.00313	CcSEcCtD
Rimexolone—Pruritus—Conjugated Estrogens—prostate cancer	8.23e-05	0.0031	CcSEcCtD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—prostate cancer	8.2e-05	0.00901	CbGpPWpGaD
Rimexolone—Rhinitis—Capecitabine—prostate cancer	8.19e-05	0.00309	CcSEcCtD
Rimexolone—Pharyngitis—Capecitabine—prostate cancer	8.11e-05	0.00306	CcSEcCtD
Rimexolone—Hypotension—Mitoxantrone—prostate cancer	8.1e-05	0.00305	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—ASCL1—prostate cancer	8.03e-05	0.00882	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—prostate cancer	7.8e-05	0.00857	CbGpPWpGaD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—prostate cancer	7.7e-05	0.00846	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptors—AR—prostate cancer	7.7e-05	0.00846	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—prostate cancer	7.65e-05	0.0084	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptors—RXRA—prostate cancer	7.64e-05	0.00839	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—NPPA—prostate cancer	7.45e-05	0.00818	CbGpPWpGaD
Rimexolone—Discomfort—Etoposide—prostate cancer	7.43e-05	0.0028	CcSEcCtD
Rimexolone—Headache—Goserelin—prostate cancer	7.35e-05	0.00277	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—NCOA2—prostate cancer	7.3e-05	0.00802	CbGpPWpGaD
Rimexolone—Headache—Conjugated Estrogens—prostate cancer	7.28e-05	0.00275	CcSEcCtD
Rimexolone—Dysgeusia—Docetaxel—prostate cancer	7.19e-05	0.00271	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—NCOA2—prostate cancer	7.09e-05	0.00779	CbGpPWpGaD
Rimexolone—NR3C1—lymph node—prostate cancer	7.06e-05	0.0298	CbGeAlD
Rimexolone—NR3C1—AP-1 transcription factor network—ATF3—prostate cancer	7.05e-05	0.00775	CbGpPWpGaD
Rimexolone—Hydrocortisone—ANXA1—prostate cancer	7.05e-05	0.0313	CrCbGaD
Rimexolone—Dysgeusia—Capecitabine—prostate cancer	6.96e-05	0.00262	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptors—VDR—prostate cancer	6.92e-05	0.0076	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—ESR2—prostate cancer	6.89e-05	0.00757	CbGpPWpGaD
Rimexolone—Hypotension—Etoposide—prostate cancer	6.74e-05	0.00254	CcSEcCtD
Rimexolone—Testolactone—CYP19A1—prostate cancer	6.72e-05	0.0299	CrCbGaD
Rimexolone—Vision blurred—Capecitabine—prostate cancer	6.7e-05	0.00253	CcSEcCtD
Rimexolone—Dexamethasone—CYP3A43—prostate cancer	6.64e-05	0.0295	CrCbGaD
Rimexolone—Pruritus—Estradiol—prostate cancer	6.58e-05	0.00248	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—PTHLH—prostate cancer	6.48e-05	0.00712	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	6.28e-05	0.00689	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—EGR1—prostate cancer	6.25e-05	0.00686	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—MIF—prostate cancer	6.2e-05	0.00681	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—NCOA1—prostate cancer	6.15e-05	0.00676	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—AR—prostate cancer	6.08e-05	0.00668	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—RXRA—prostate cancer	6.04e-05	0.00663	CbGpPWpGaD
Rimexolone—Oedema—Docetaxel—prostate cancer	5.99e-05	0.00226	CcSEcCtD
Rimexolone—Discomfort—Capecitabine—prostate cancer	5.98e-05	0.00225	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—NCOA1—prostate cancer	5.97e-05	0.00656	CbGpPWpGaD
Rimexolone—Vision blurred—Prednisone—prostate cancer	5.97e-05	0.00225	CcSEcCtD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—prostate cancer	5.96e-05	0.00655	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—EZH2—prostate cancer	5.9e-05	0.00648	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—AR—prostate cancer	5.9e-05	0.00648	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—prostate cancer	5.89e-05	0.00647	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—RXRA—prostate cancer	5.85e-05	0.00643	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptors—PPARA—prostate cancer	5.83e-05	0.00641	CbGpPWpGaD
Rimexolone—Headache—Estradiol—prostate cancer	5.83e-05	0.0022	CcSEcCtD
Rimexolone—Oedema—Capecitabine—prostate cancer	5.8e-05	0.00219	CcSEcCtD
Rimexolone—Rhinitis—Epirubicin—prostate cancer	5.71e-05	0.00215	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—RXRA—prostate cancer	5.68e-05	0.00624	CbGpPWpGaD
Rimexolone—Pharyngitis—Epirubicin—prostate cancer	5.65e-05	0.00213	CcSEcCtD
Rimexolone—Difluprednate—NR3C1—prostate cancer	5.62e-05	0.0249	CrCbGaD
Rimexolone—Hypotension—Docetaxel—prostate cancer	5.6e-05	0.00211	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—VDR—prostate cancer	5.47e-05	0.006	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—PRKACB—prostate cancer	5.46e-05	0.006	CbGpPWpGaD
Rimexolone—Clocortolone—NR3C1—prostate cancer	5.45e-05	0.0242	CrCbGaD
Rimexolone—Prednicarbate—NR3C1—prostate cancer	5.45e-05	0.0242	CrCbGaD
Rimexolone—Headache—Mitoxantrone—prostate cancer	5.43e-05	0.00205	CcSEcCtD
Rimexolone—Hypotension—Capecitabine—prostate cancer	5.42e-05	0.00204	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—SIRT1—prostate cancer	5.38e-05	0.00591	CbGpPWpGaD
Rimexolone—Discomfort—Prednisone—prostate cancer	5.33e-05	0.00201	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—TH—prostate cancer	5.31e-05	0.00583	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—prostate cancer	5.29e-05	0.00581	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptors—ESR1—prostate cancer	5.29e-05	0.00581	CbGpPWpGaD
Rimexolone—Rhinitis—Doxorubicin—prostate cancer	5.28e-05	0.00199	CcSEcCtD
Rimexolone—Dexamethasone—ANXA1—prostate cancer	5.25e-05	0.0233	CrCbGaD
Rimexolone—Pharyngitis—Doxorubicin—prostate cancer	5.23e-05	0.00197	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	5.2e-05	0.00571	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	5.18e-05	0.00569	CbGpPWpGaD
Rimexolone—Oedema—Prednisone—prostate cancer	5.17e-05	0.00195	CcSEcCtD
Rimexolone—Desonide—NR3C1—prostate cancer	5.15e-05	0.0229	CrCbGaD
Rimexolone—Diflorasone—NR3C1—prostate cancer	5.15e-05	0.0229	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—prostate cancer	5.15e-05	0.00566	CbGpPWpGaD
Rimexolone—Pruritus—Etoposide—prostate cancer	5.1e-05	0.00192	CcSEcCtD
Rimexolone—Desoximetasone—NR3C1—prostate cancer	5.03e-05	0.0223	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—EGR1—prostate cancer	5e-05	0.00549	CbGpPWpGaD
Rimexolone—Loteprednol—NR3C1—prostate cancer	4.97e-05	0.0221	CrCbGaD
Rimexolone—Dysgeusia—Epirubicin—prostate cancer	4.85e-05	0.00183	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—GJA1—prostate cancer	4.76e-05	0.00523	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—prostate cancer	4.73e-05	0.0052	CbGpPWpGaD
Rimexolone—Beclomethasone—CYP3A5—prostate cancer	4.7e-05	0.0209	CrCbGaD
Rimexolone—Vision blurred—Epirubicin—prostate cancer	4.67e-05	0.00176	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—AHR—prostate cancer	4.66e-05	0.00512	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—PPARA—prostate cancer	4.61e-05	0.00506	CbGpPWpGaD
Rimexolone—Medrysone—NR3C1—prostate cancer	4.56e-05	0.0203	CrCbGaD
Rimexolone—Headache—Etoposide—prostate cancer	4.52e-05	0.0017	CcSEcCtD
Rimexolone—Dysgeusia—Doxorubicin—prostate cancer	4.49e-05	0.00169	CcSEcCtD
Rimexolone—NR3C1—Generic Transcription Pathway—ZNF160—prostate cancer	4.48e-05	0.00492	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—prostate cancer	4.44e-05	0.00487	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—prostate cancer	4.41e-05	0.00484	CbGpPWpGaD
Rimexolone—Flurandrenolide—NR3C1—prostate cancer	4.4e-05	0.0195	CrCbGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	4.38e-05	0.00481	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—PPARA—prostate cancer	4.34e-05	0.00477	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—prostate cancer	4.34e-05	0.00477	CbGpPWpGaD
Rimexolone—Flumethasone Pivalate—NR3C1—prostate cancer	4.33e-05	0.0192	CrCbGaD
Rimexolone—Vision blurred—Doxorubicin—prostate cancer	4.32e-05	0.00163	CcSEcCtD
Rimexolone—Halobetasol Propionate—NR3C1—prostate cancer	4.26e-05	0.0189	CrCbGaD
Rimexolone—Hydrocortamate—NR3C1—prostate cancer	4.26e-05	0.0189	CrCbGaD
Rimexolone—Pruritus—Docetaxel—prostate cancer	4.24e-05	0.0016	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—HIF1A—prostate cancer	4.22e-05	0.00463	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—prostate cancer	4.21e-05	0.00462	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—prostate cancer	4.2e-05	0.00462	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—prostate cancer	4.18e-05	0.00459	CbGpPWpGaD
Rimexolone—Discomfort—Epirubicin—prostate cancer	4.17e-05	0.00157	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—IL10—prostate cancer	4.13e-05	0.00453	CbGpPWpGaD
Rimexolone—Pruritus—Capecitabine—prostate cancer	4.11e-05	0.00155	CcSEcCtD
Rimexolone—Oedema—Epirubicin—prostate cancer	4.04e-05	0.00152	CcSEcCtD
Rimexolone—Budesonide—NR3C1—prostate cancer	3.96e-05	0.0176	CrCbGaD
Rimexolone—Amcinonide—NR3C1—prostate cancer	3.96e-05	0.0176	CrCbGaD
Rimexolone—Discomfort—Doxorubicin—prostate cancer	3.86e-05	0.00145	CcSEcCtD
Rimexolone—Hypotension—Epirubicin—prostate cancer	3.78e-05	0.00142	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—prostate cancer	3.78e-05	0.00415	CbGpPWpGaD
Rimexolone—Mometasone—NR3C1—prostate cancer	3.76e-05	0.0167	CrCbGaD
Rimexolone—Headache—Docetaxel—prostate cancer	3.76e-05	0.00142	CcSEcCtD
Rimexolone—Oedema—Doxorubicin—prostate cancer	3.74e-05	0.00141	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—GSK3B—prostate cancer	3.67e-05	0.00404	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	3.67e-05	0.00403	CbGpPWpGaD
Rimexolone—Pruritus—Prednisone—prostate cancer	3.66e-05	0.00138	CcSEcCtD
Rimexolone—Headache—Capecitabine—prostate cancer	3.64e-05	0.00137	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—NCOA2—prostate cancer	3.56e-05	0.00391	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—CREBBP—prostate cancer	3.55e-05	0.0039	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—BAX—prostate cancer	3.54e-05	0.00389	CbGpPWpGaD
Rimexolone—Fluocinonide—NR3C1—prostate cancer	3.51e-05	0.0156	CrCbGaD
Rimexolone—Beclomethasone—NR3C1—prostate cancer	3.51e-05	0.0156	CrCbGaD
Rimexolone—Hypotension—Doxorubicin—prostate cancer	3.5e-05	0.00132	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—HIF1A—prostate cancer	3.48e-05	0.00382	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—GADD45A—prostate cancer	3.45e-05	0.00379	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—CREBBP—prostate cancer	3.45e-05	0.00379	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—PLAU—prostate cancer	3.45e-05	0.00378	CbGpPWpGaD
Rimexolone—Alclometasone—NR3C1—prostate cancer	3.41e-05	0.0151	CrCbGaD
Rimexolone—Fluocinolone Acetonide—NR3C1—prostate cancer	3.41e-05	0.0151	CrCbGaD
Rimexolone—Clobetasol propionate—NR3C1—prostate cancer	3.32e-05	0.0147	CrCbGaD
Rimexolone—Flunisolide—NR3C1—prostate cancer	3.32e-05	0.0147	CrCbGaD
Rimexolone—Paramethasone—NR3C1—prostate cancer	3.28e-05	0.0146	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	3.26e-05	0.00359	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—ESR1—prostate cancer	3.24e-05	0.00356	CbGpPWpGaD
Rimexolone—Headache—Prednisone—prostate cancer	3.24e-05	0.00122	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—SERPINE1—prostate cancer	3.23e-05	0.00355	CbGpPWpGaD
Rimexolone—Ciclesonide—NR3C1—prostate cancer	3.23e-05	0.0143	CrCbGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—prostate cancer	3.22e-05	0.00354	CbGpPWpGaD
Rimexolone—Fluorometholone—NR3C1—prostate cancer	3.2e-05	0.0142	CrCbGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—prostate cancer	3.2e-05	0.00351	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—APC—prostate cancer	3.14e-05	0.00345	CbGpPWpGaD
Rimexolone—Fluticasone Propionate—CYP3A5—prostate cancer	3.12e-05	0.0139	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—TBX5—prostate cancer	3.1e-05	0.00341	CbGpPWpGaD
Rimexolone—Methylprednisolone—NR3C1—prostate cancer	3.09e-05	0.0137	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	3.04e-05	0.00334	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—MDM2—prostate cancer	3.02e-05	0.00331	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP17A1—prostate cancer	3.02e-05	0.0134	CrCbGaD
Rimexolone—Clobetasol propionate—CYP1A1—prostate cancer	3.02e-05	0.0134	CrCbGaD
Rimexolone—NR3C1—Adipogenesis—NCOA1—prostate cancer	3e-05	0.0033	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	2.89e-05	0.00317	CbGpPWpGaD
Rimexolone—Pruritus—Epirubicin—prostate cancer	2.86e-05	0.00108	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—RXRA—prostate cancer	2.86e-05	0.00314	CbGpPWpGaD
Rimexolone—Prednisolone—CYP2A6—prostate cancer	2.83e-05	0.0126	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—ESR2—prostate cancer	2.82e-05	0.00309	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—prostate cancer	2.81e-05	0.00309	CbGpPWpGaD
Rimexolone—Hydrocortisone—SHBG—prostate cancer	2.81e-05	0.0125	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—TH—prostate cancer	2.8e-05	0.00307	CbGpPWpGaD
Rimexolone—Pruritus—Doxorubicin—prostate cancer	2.65e-05	0.000998	CcSEcCtD
Rimexolone—Betamethasone—CYP19A1—prostate cancer	2.64e-05	0.0117	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—EGR1—prostate cancer	2.63e-05	0.00289	CbGpPWpGaD
Rimexolone—Triamcinolone—NR3C1—prostate cancer	2.61e-05	0.0116	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—prostate cancer	2.59e-05	0.00285	CbGpPWpGaD
Rimexolone—Headache—Epirubicin—prostate cancer	2.53e-05	0.000955	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	2.53e-05	0.00278	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—GJA1—prostate cancer	2.51e-05	0.00275	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—prostate cancer	2.5e-05	0.00275	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—AR—prostate cancer	2.49e-05	0.00273	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—LPL—prostate cancer	2.47e-05	0.00271	CbGpPWpGaD
Rimexolone—Hydrocortamate—CYP3A4—prostate cancer	2.47e-05	0.011	CrCbGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—EP300—prostate cancer	2.42e-05	0.00266	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	2.37e-05	0.0026	CbGpPWpGaD
Rimexolone—Prednisone—NR3C1—prostate cancer	2.37e-05	0.0105	CrCbGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	2.35e-05	0.00258	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—EP300—prostate cancer	2.35e-05	0.00258	CbGpPWpGaD
Rimexolone—Headache—Doxorubicin—prostate cancer	2.34e-05	0.000883	CcSEcCtD
Rimexolone—Fluticasone Propionate—NR3C1—prostate cancer	2.33e-05	0.0104	CrCbGaD
Rimexolone—Budesonide—CYP3A4—prostate cancer	2.29e-05	0.0102	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	2.26e-05	0.00248	CbGpPWpGaD
Rimexolone—Hydrocortisone—CYP3A5—prostate cancer	2.23e-05	0.00992	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	2.2e-05	0.00242	CbGpPWpGaD
Rimexolone—Prednisolone—NR3C1—prostate cancer	2.18e-05	0.00969	CrCbGaD
Rimexolone—NR3C1—Adipogenesis—PPARA—prostate cancer	2.18e-05	0.0024	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	2.17e-05	0.00239	CbGpPWpGaD
Rimexolone—Prednisone—CYP2C19—prostate cancer	2.16e-05	0.00958	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	2.16e-05	0.00237	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—BAZ2A—prostate cancer	2.16e-05	0.00237	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—SSR2—prostate cancer	2.16e-05	0.00237	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ZNF160—prostate cancer	2.16e-05	0.00237	CbGpPWpGaD
Rimexolone—Betamethasone—NR3C1—prostate cancer	2.14e-05	0.00949	CrCbGaD
Rimexolone—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	2.13e-05	0.00234	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	2.13e-05	0.00234	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—HIF1A—prostate cancer	2.12e-05	0.00233	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	2.1e-05	0.00231	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP1B1—prostate cancer	2.09e-05	0.00928	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	2.08e-05	0.00229	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—LEP—prostate cancer	2.07e-05	0.00227	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	2.04e-05	0.00224	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	2.03e-05	0.00223	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	1.99e-05	0.00218	CbGpPWpGaD
Rimexolone—Alclometasone—CYP3A4—prostate cancer	1.98e-05	0.00878	CrCbGaD
Rimexolone—NR3C1—Gene Expression—HNRNPH1—prostate cancer	1.97e-05	0.00217	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	1.94e-05	0.00213	CbGpPWpGaD
Rimexolone—Flunisolide—CYP3A4—prostate cancer	1.92e-05	0.00855	CrCbGaD
Rimexolone—Paramethasone—CYP3A4—prostate cancer	1.9e-05	0.00844	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	1.9e-05	0.00209	CbGpPWpGaD
Rimexolone—Ciclesonide—CYP3A4—prostate cancer	1.87e-05	0.0083	CrCbGaD
Rimexolone—Fluorometholone—CYP3A4—prostate cancer	1.86e-05	0.00824	CrCbGaD
Rimexolone—NR3C1—Adipogenesis—IRS1—prostate cancer	1.85e-05	0.00203	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NFIC—prostate cancer	1.83e-05	0.00201	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	1.83e-05	0.00201	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	1.81e-05	0.00199	CbGpPWpGaD
Rimexolone—Methylprednisolone—CYP3A4—prostate cancer	1.79e-05	0.00796	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	1.79e-05	0.00197	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—INS—prostate cancer	1.77e-05	0.00194	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPN2—prostate cancer	1.72e-05	0.00189	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	1.72e-05	0.00189	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	1.72e-05	0.00189	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—IGF1—prostate cancer	1.71e-05	0.00188	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	1.71e-05	0.00187	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	1.7e-05	0.00186	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	1.69e-05	0.00185	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	1.68e-05	0.00185	CbGpPWpGaD
Rimexolone—Hydrocortisone—NR3C1—prostate cancer	1.67e-05	0.00741	CrCbGaD
Rimexolone—Dexamethasone—CYP3A5—prostate cancer	1.66e-05	0.00739	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	1.66e-05	0.00182	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—QARS—prostate cancer	1.63e-05	0.00179	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	1.63e-05	0.00179	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—SERPINE1—prostate cancer	1.62e-05	0.00178	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP2A6—prostate cancer	1.61e-05	0.00716	CrCbGaD
Rimexolone—Dexamethasone—CYP19A1—prostate cancer	1.53e-05	0.00681	CrCbGaD
Rimexolone—Triamcinolone—CYP3A4—prostate cancer	1.51e-05	0.00672	CrCbGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	1.5e-05	0.00165	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	1.5e-05	0.00164	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—TBX5—prostate cancer	1.49e-05	0.00164	CbGpPWpGaD
Rimexolone—Triamcinolone—PTGS2—prostate cancer	1.48e-05	0.00658	CrCbGaD
Rimexolone—NR3C1—Gene Expression—EIF3H—prostate cancer	1.39e-05	0.00153	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	1.39e-05	0.00152	CbGpPWpGaD
Rimexolone—Prednisone—CYP3A4—prostate cancer	1.37e-05	0.00609	CrCbGaD
Rimexolone—Fluticasone Propionate—CYP3A4—prostate cancer	1.35e-05	0.006	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	1.3e-05	0.00143	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.27e-05	0.00139	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.27e-05	0.00139	CbGpPWpGaD
Rimexolone—Prednisolone—CYP3A4—prostate cancer	1.26e-05	0.00561	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.26e-05	0.00138	CbGpPWpGaD
Rimexolone—Dexamethasone—NR3C1—prostate cancer	1.24e-05	0.00552	CrCbGaD
Rimexolone—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.24e-05	0.00136	CbGpPWpGaD
Rimexolone—Betamethasone—CYP3A4—prostate cancer	1.24e-05	0.0055	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.22e-05	0.00134	CbGpPWpGaD
Rimexolone—Betamethasone—PTGS2—prostate cancer	1.21e-05	0.00539	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.19e-05	0.00131	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.19e-05	0.00131	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP2E1—prostate cancer	1.14e-05	0.00508	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.14e-05	0.00125	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP2C19—prostate cancer	1.13e-05	0.00503	CrCbGaD
Rimexolone—NR3C1—Gene Expression—MBD2—prostate cancer	1.13e-05	0.00124	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—TET2—prostate cancer	1.13e-05	0.00124	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP1A1—prostate cancer	1.13e-05	0.00501	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.12e-05	0.00123	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPL12—prostate cancer	1.11e-05	0.00122	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—STAT3—prostate cancer	1.11e-05	0.00121	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.1e-05	0.0012	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.1e-05	0.0012	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.05e-05	0.00115	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.04e-05	0.00115	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.04e-05	0.00114	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.03e-05	0.00113	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.03e-05	0.00113	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EIF3A—prostate cancer	1.02e-05	0.00112	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.02e-05	0.00112	CbGpPWpGaD
Rimexolone—Hydrocortisone—CYP3A4—prostate cancer	9.67e-06	0.00429	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	9.66e-06	0.00106	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	9.44e-06	0.00104	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—DNMT3B—prostate cancer	8.58e-06	0.000943	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPL10—prostate cancer	8.42e-06	0.000925	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	8.26e-06	0.000908	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HIST1H4H—prostate cancer	7.98e-06	0.000877	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NPPA—prostate cancer	7.98e-06	0.000877	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	7.96e-06	0.000875	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MED12—prostate cancer	7.85e-06	0.000862	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—IL6—prostate cancer	7.73e-06	0.000849	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	7.22e-06	0.000792	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP3A4—prostate cancer	7.21e-06	0.0032	CrCbGaD
Rimexolone—Dexamethasone—PTGS2—prostate cancer	7.05e-06	0.00313	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	6.68e-06	0.000733	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPS19—prostate cancer	6.68e-06	0.000733	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—DNMT1—prostate cancer	6.38e-06	0.000701	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	6.32e-06	0.000695	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NCOA2—prostate cancer	6.26e-06	0.000688	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EZH2—prostate cancer	6.18e-06	0.000679	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—PARP1—prostate cancer	6.05e-06	0.000664	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	5.93e-06	0.000651	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HSPA1A—prostate cancer	5.73e-06	0.000629	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ESR2—prostate cancer	5.73e-06	0.000629	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NCOA1—prostate cancer	5.28e-06	0.00058	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—AR—prostate cancer	5.06e-06	0.000556	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RXRA—prostate cancer	5.02e-06	0.000551	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—SIRT1—prostate cancer	4.61e-06	0.000507	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—VDR—prostate cancer	4.55e-06	0.000499	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ERCC2—prostate cancer	4.16e-06	0.000457	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—PPARA—prostate cancer	3.83e-06	0.000421	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	3.75e-06	0.000412	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ESR1—prostate cancer	3.47e-06	0.000382	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—CREBBP—prostate cancer	3.04e-06	0.000334	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—SERPINE1—prostate cancer	2.86e-06	0.000314	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MYC—prostate cancer	1.81e-06	0.000198	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—AKT1—prostate cancer	1.25e-06	0.000138	CbGpPWpGaD
